The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India
- Supplementary File 1:
ZIP-Document (ZIP, 7002 KiB)
Attarde, S.; Iyer, A.; Khochare, S.; Shaligram, U.; Vikharankar, M.; Sunagar, K. The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India. Toxins 2022, 14, 168. https://doi.org/10.3390/toxins14030168
Attarde S, Iyer A, Khochare S, Shaligram U, Vikharankar M, Sunagar K. The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India. Toxins. 2022; 14(3):168. https://doi.org/10.3390/toxins14030168
Chicago/Turabian StyleAttarde, Saurabh, Ashwin Iyer, Suyog Khochare, Umesh Shaligram, Mayur Vikharankar, and Kartik Sunagar. 2022. "The Preclinical Evaluation of a Second-Generation Antivenom for Treating Snake Envenoming in India" Toxins 14, no. 3: 168. https://doi.org/10.3390/toxins14030168